keyword
https://read.qxmd.com/read/38656158/multicomponent-pathogen-mimicking-nanoparticles-induce-intestinal-immune-responses-against-paratuberculosis
#1
JOURNAL ARTICLE
Yiduo Liu, Meizhen Long, Yuanzhi Wang, Zhengmin Liang, Yuhui Dong, Mengjin Qu, Xin Ge, Yue Nan, Yulan Chen, Xiangmei Zhou
Given the worldwide problem posed by enteric pathogens, the discovery of safe and efficient intestinal adjuvants combined with novel antigen delivery techniques is essential to the design of mucosal vaccines. In this work, we designed poly (lactic-co-glycolic acid) (PLGA)-based nanoparticles (NPs) to codeliver all-trans retinoic acid (atRA), novel antigens, and CpG. To address the insolubility of the intestinal adjuvant atRA, we utilized PLGA to encapsulate atRA and form a "nanocapsid" with polydopamine. By leveraging polydopamine, we adsorbed the water-soluble antigens and the TLR9 agonist CpG onto the NPs' surface, resulting in the pathogen-mimicking PLPCa NPs...
April 24, 2024: ACS Biomaterials Science & Engineering
https://read.qxmd.com/read/38647241/jynneos-vaccine-safety-surveillance-during-the-2022-mpox-outbreak-using-the-vaccine-adverse-event-reporting-system-vaers-and-v-safe-united-states-2022-2023
#2
JOURNAL ARTICLE
Jonathan Duffy, Tanya R Myers, Paige Marquez, Douglas Rouse, Hannah Brown, Bicheng Zhang, David K Shay, Pedro L Moro
BACKGROUND: In response to the 2022 mpox outbreak in the United States, people with higher potential for exposure to mpox were recommended to receive two doses of the JYNNEOS vaccine. Vaccine safety was monitored using two complementary systems. METHODS: The Vaccine Adverse Event Reporting System (VAERS) is a passive surveillance system that accepts reports of adverse events following vaccination. VAERS is capable of rapidly identifying rare adverse events and unusual reporting patterns...
April 19, 2024: Sexually Transmitted Diseases
https://read.qxmd.com/read/38645568/sustained-release-local-anesthetics-for-pain-management-relevance-and-formulation-approaches
#3
REVIEW
Melese Getachew, Hana Tesfaye, Wubetu Yihunie, Tesfahun Ayenew, Sintayehu Alemu, Ephrem Mebratu Dagnew, Yalemgeta Biyazin, Dehnnet Abebe, Natanim Degefu, Abtie Abebaw
This review attempted to ascertain the rationale for the formulation of sustained-release local anesthetics and summarize the various formulation approaches designed to date to achieve sustained and localized local analgesic effects. The incidence of pain, which is the concern of patients as well as health care professionals, is increasing due to accidents, surgical procedures, and other diseases. Local anesthetics can be used for the management of moderate to severe acute and chronic pain. They also allow regional analgesia, in situations where the cause and source of the pain are limited to a particular site or region, without the need for loss of consciousness or systemic administration of other analgesics thereby decreasing the risk of potential toxicities...
2024: Front Pain Res (Lausanne)
https://read.qxmd.com/read/38625037/transfer-of-ans-like-drugs-from-micellar-drug-delivery-systems-to-albumin-is-highly-favorable-and-protected-from-competition-with-surfactant-by-reserved-binding-sites
#4
JOURNAL ARTICLE
Iulia Carabadjac, Leonie C Vormittag, Thomas Muszer, Jakob Wuth, Maximilian H Ulbrich, Heiko Heerklotz
Micellar drug delivery systems (MDDS) for the intravenous administration of poorly soluble drugs have great advantages over alternative formulations in terms of the safety of their excipients, storage stability, and straightforward production. A classic example is mixed micelles of glycocholate (GC) and lecithin, both endogenous substances in human blood. What limits the use of MDDS is the complexity of the transitions after injection. In particular, as the MDDS disintegrate partially or completely after injection, the drug has to be transferred safely to endogenous carriers in the blood, such as human serum albumin (HSA)...
April 16, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38623193/covid-19-vaccinations-for-patients-with-epilepsy-in-guizhou-province-china-a-cross-sectional-study
#5
JOURNAL ARTICLE
Qian Zheng, Yong-Ran Cheng, Mingwei Wang, Xuntai Ma, Lan Ye, Zucai Xu, Zhanhui Feng
Several COVID-19 vaccines have been approved for emergency use according to China's immunization programs. These vaccines has created hope for patients with epilepsy, because the vaccines can help to reduce their risk of becoming infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The aim of this study was to investigate the COVID-19 vaccine safety in patients with epilepsy. Here, we assessed the time of symptom control and the features of adverse events of seizure patients following their COVID-19 vaccinations...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38619705/microneedle-patch-with-pure-drug-tips-for-delivery-of-liraglutide-pharmacokinetics-in-rats-and-minipigs
#6
JOURNAL ARTICLE
Hongbing Lin, Jinbin Liu, Yulin Hou, Zhiyan Yu, Juan Hong, Jianghong Yu, Yu Chen, Jingwen Hu, Dengning Xia
Transdermal delivery of peptide drugs is almost impossible with conventional penetration enhancers because of epidermal barrier function. Microneedle (MN) patches can bypass the epidermal barrier and have been developed for trans- and intradermal delivery of peptide drugs and vaccines. However, dissolving MN patches are limited by low drug loading capacities due to their small size and admixture of drug and water-soluble excipients. Furthermore, few in vivo pharmacokinetic studies, especially in large animals such as pigs, have been performed to assess post-application systemic drug exposure...
April 15, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38614633/efficacy-of-assisted-partner-services-for-people-who-inject-drugs-in-kenya-to-identify-partners-living-with-hiv-and-hepatitis-c-virus-infection-a-prospective-cohort-study
#7
JOURNAL ARTICLE
Aliza Monroe-Wise, Loice Mbogo, Betsy Sambai, Natasha Ludwig-Barron, Brandon L Guthrie, David Bukusi, Bhavna H Chohan, Sarah Masyuko, John Scott, Emily Juma, Paul Macharia, Hanley Kingston, William Sinkele, Esther Gitau, Rose Bosire, Helgar Musyoki, Joshua Herbeck, Carey Farquhar
BACKGROUND: People who inject drugs are at increased risk of both HIV and hepatitis C virus (HCV) infections but face barriers to testing and engagement in care. Assisted partner services are effective in locating people with HIV but are understudied among people who inject drugs. We assessed whether assisted partner services could be used to find, test for HIV and HCV infections, and link to care the partners of people who inject drugs in Kenya. METHODS: In this prospective study at eight sites offering harm-reduction services in Kenya, we enrolled people aged 18 years or older who inject drugs and were living with HIV (index participants) between Feb 27, 2018, and Nov 1, 2021...
May 2024: Lancet Global Health
https://read.qxmd.com/read/38607080/cell-membrane-fragment-wrapped-parenteral-nanoemulsions-a-new-drug-delivery-tool-to-target-gliomas
#8
JOURNAL ARTICLE
Chiara Dianzani, Annalisa Bozza, Valentina Bordano, Luigi Cangemi, Chiara Ferraris, Federica Foglietta, Chiara Monge, Margherita Gallicchio, Stefania Pizzimenti, Elisabetta Marini, Elisabetta Muntoni, Maria Carmen Valsania, Luigi Battaglia
Poor prognosis in high-grade gliomas is mainly due to fatal relapse after surgical resection in the absence of efficient chemotherapy, which is severely hampered by the blood-brain barrier. However, the leaky blood-brain-tumour barrier forms upon tumour growth and vascularization, allowing targeted nanocarrier-mediated drug delivery. The homotypic targeting ability of cell-membrane fragments obtained from cancer cells means that these fragments can be exploited to this aim. In this experimental work, injectable nanoemulsions, which have a long history of safe clinic usage, have been wrapped in glioma-cell membrane fragments via co-extrusion to give targeted, homogeneously sized, sterile formulations...
April 6, 2024: Cells
https://read.qxmd.com/read/38601118/mesenchymal-stem-cell-based-therapies-for-treating-well-studied-neurological-disorders-a-systematic-review
#9
Gaurav Deepak Patel, Lichao Liu, Ailian Li, Yun-Hsuan Yang, Chia-Chi Shen, Beate Brand-Saberi, Xuesong Yang
BACKGROUND: Millions of people across the globe are affected by conditions like Amyotrophic Lateral Sclerosis (ALS), Parkinson's Disease (PD), Multiple Sclerosis (MS), Spinal Cord Injury (SCI), and Traumatic Brain Injury (TBI), although most occurrences are common in the elderly population. This systematic review aims to highlight the safety of the procedures, their tolerability, and efficacy of the available therapies conducted over the years using mesenchymal stem cells (MSCs) in treating the neurological conditions mentioned above...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38569556/carrier-free-mrna-vaccine-induces-robust-immunity-against-sars-cov-2-in-mice-and-non-human-primates-without-systemic-reactogenicity
#10
JOURNAL ARTICLE
Saed Abbasi, Miki Matsui-Masai, Fumihiko Yasui, Akimasa Hayashi, Theofilus A Tockary, Yuki Mochida, Shiro Akinaga, Michinori Kohara, Kazunori Kataoka, Satoshi Uchida
Carrier-free naked mRNA vaccines may reduce the reactogenicity associated with delivery carriers; however, their effectiveness against infectious diseases has been suboptimal. To boost efficacy, we targeted the skin layer rich in antigen-presenting cells (APCs) and utilized a jet injector. The jet injection efficiently introduced naked mRNA into skin cells, including APCs in mice. Further analyses indicated that APCs, after taking up antigen mRNA in the skin, migrated to the lymph nodes (LNs) for antigen presentation...
March 22, 2024: Molecular Therapy
https://read.qxmd.com/read/38561815/a-pragmatic-randomized-controlled-trial-to-evaluate-the-efficacy-and-safety-of-an-oral-short-course-regimen-including-bedaquiline-for-the-treatment-of-patients-with-multidrug-resistant-tuberculosis-in-china-study-protocol-for-prospect
#11
JOURNAL ARTICLE
Jingtao Gao, Mengqiu Gao, Jian Du, Yu Pang, Gary Mao, Nacer Lounis, Nyasha Bakare, Yanxin Jiang, Ying Zhan, Yuhong Liu, Liang Li
INTRODUCTION: The lack of safe, effective, and simple short-course regimens (SCRs) for multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) treatment has significantly impeded TB control efforts in China. METHODS: This phase 4, randomized, open-label, controlled, non-inferiority trial aims to assess the efficacy and safety of a 9-month all-oral SCR containing bedaquiline (BDQ) versus an all-oral SCR without BDQ for adult MDR-TB patients (18-65 years) in China...
April 1, 2024: Trials
https://read.qxmd.com/read/38558211/consideration-of-the-diameter-of-superficial-temporal-arteries-related-to-filler-injections-in-the-temporal-region
#12
JOURNAL ARTICLE
Jung-Hee Bae, Soo Hyun Park, Kyu-Ho Yi
BACKGROUND: The concavity of the temple due to adipose tissue atrophy from aging accentuates the zygomatic arch and lateral orbital rim, leading to an aged appearance. The use of hyaluronic acid filler in the temporal region has gained popularity due to its procedural simplicity and consistent outcomes. OBJECTIVE: To evaluate the safety of administering hyaluronic acid filler in the temporal region concerning the frontal branch of the superficial temporal artery, which is at risk of injury...
April 2024: Skin Research and Technology
https://read.qxmd.com/read/38556793/crispr-cas9n-mediated-elane-promoter-editing-for-gene-therapy-of-severe-congenital-neutropenia
#13
JOURNAL ARTICLE
Masoud Nasri, Malte Ritter, Perihan Mir, Benjamin Dannenmann, Masako M Kaufmann, Patricia Arreba-Tutusaus, Yun Xu, Natalia Borbaran-Bravo, Maksim Klimiankou, Claudia Lengerke, Cornelia Zeidler, Toni Cathomen, Karl Welte, Julia Skokowa
Severe congenital neutropenia (CN) is an inherited pre-leukemia bone marrow failure syndrome commonly caused by autosomal-dominant ELANE mutations (ELANE-CN). ELANE-CN patients are treated with daily injections of recombinant human granulocyte colony-stimulating factor (rhG-CSF). However, some patients do not respond to rhG-CSF, and approximately 15% of ELANE-CN patients develop myelodysplasia or acute myeloid leukemia. Here, we report the development of a curative therapy for ELANE-CN through inhibition of ELANE mRNA expression by introducing two single-strand DNA breaks at the opposing DNA strands of the ELANE promoter TATA-box using CRISPR/Cas9D10A nickases - termed MILESTONE...
March 30, 2024: Molecular Therapy
https://read.qxmd.com/read/38550815/efficacy-and-safety-of-carbon-dioxide-laser-ablation-combined-with-manual-dermabrasion-and-intralesional-5-fluorouracil-injection-in-bowen-s-disease
#14
JOURNAL ARTICLE
Sushil S Savant, Satish S Savant
BACKGROUND: Bowen's disease (BD) is a precancerous in-situ squamous cell carcinoma and has a high recurrence rate with any single treatment modality, necessitating combination therapy for a successful outcome. AIM: This study aimed to the efficacy and safety of carbon dioxide (CO2 ) laser ablation followed by manual dermabrasion and intralesional 5-fluorouracil (IL 5-FU) injection as combination therapy for BD. MATERIALS AND METHODS: This was a retrospective, observational study comprising 29 clinically and histopathologically diagnosed BD patients with no history of prior treatment...
2024: Indian Dermatology Online Journal
https://read.qxmd.com/read/38549951/safety-and-immunogenicity-of-coronavac-and-chadox1-heterologous-prime-boost-vaccines-in-an-overweight-population-in-chiang-mai-thailand
#15
JOURNAL ARTICLE
Kriangkrai Chawansuntati, Supachai Sakkhachornphop, Sayamon Hongjaisee, Saranta Freeouf, Patumrat Sripan, Nattaya Nusartsang, Romanee Chaiwarith, Tavitiya Sudjaritruk, Khuanchai Supparatpinyo, Jiraprapa Wipasa
BACKGROUND: In early 2021, the Ministry of Public Health of Thailand announced heterologous regimens for COVID-19 vaccines using CoronaVac as the first dose followed by ChAdOx1 nCoV-19 at 3 weeks apart. Priority was given to individuals above 60 years old and those who had seven underlying conditions, including obesity. The vaccine regimen was evaluated for safety and immunogenicity in overweight populations in Chiang Mai, Thailand. METHODS: Participants who had a COVID-19 vaccination appointment for the heterologous prime-boost regimen were enrolled...
June 2024: Vaccine: X
https://read.qxmd.com/read/38544907/subcutaneous-vedolizumab-treatment-in-a-real-world-inflammatory-bowel-disease-cohort-switched-from-intravenous-vedolizumab-eighteen-month-prospective-follow-up-study
#16
JOURNAL ARTICLE
Thea H Wiken, Marte L Høivik, Karoline Anisdahl, Lydia Buer, David J Warren, Nils Bolstad, Milada Hagen, Bjørn A Moum, Asle W Medhus
BACKGROUND: Vedolizumab has since 2021 been available as a subcutaneous formulation. We aimed to assess 18-month drug persistence and possible predictive factors associated with discontinuation, safety, serum drug profile, drug dosing, and disease activity in a real-world cohort of patients with inflammatory bowel disease switched from intravenous to subcutaneous vedolizumab maintenance treatment. METHODS: Eligible patients were switched to subcutaneous vedolizumab and followed for 18 months or until discontinuation of subcutaneous treatment...
January 2024: Crohn's & colitis 360
https://read.qxmd.com/read/38543150/adverse-reactions-to-evolocumab-analysis-of-real-world-data-from-eudravigilance
#17
JOURNAL ARTICLE
Fabrizio Calapai, Carmen Mannucci, Mariaconcetta Currò, Luigi Cardia, Emanuela Esposito, Gioacchino Calapai, Ilaria Ammendolia
BACKGROUND: Evolocumab is a humanized immunoglobulin G2 monoclonal antibody, directed against Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9), prescribed in hypercholesterolemic patients. The safety profile of this drug is currently defined by the data of pre-authorization clinical trials. The purpose of this study is to update knowledge of the safety of evolocumab through an analysis of post-marketing real-world data on suspected adverse reactions (SARs), reported by the EudraVigilance database system...
March 11, 2024: Pharmaceuticals
https://read.qxmd.com/read/38534412/trunk-injection-delivery-of-biocontrol-strains-of-trichoderma-spp-effectively-suppresses-nut-rot-by-gnomoniopsis-castaneae-in-chestnut-castanea-sativa-mill
#18
JOURNAL ARTICLE
Alessandra Benigno, Chiara Aglietti, Santa Olga Cacciola, Salvatore Moricca
Gnomoniopsis castaneae is responsible for brown or chalky nut rot in sweet chestnut ( Castanea sativa ), causing heavy reductions in nut production. Controlling it is challenging, due to its inconspicuous infections, erratic colonization of host tissues and endophytic lifestyle. Fungicides are not applicable because they are prohibited in chestnut forests and strongly discouraged in fruit chestnut groves. Trichoderma species are safe and wide-spectrum biocontrol agents (BCAs), with a variety of beneficial effects in plant protection...
February 23, 2024: Biology
https://read.qxmd.com/read/38528839/evaluation-of-the-effectiveness-and-safety-of-sequential-vaccination-with-inactivated-sars-cov-2-vaccine-and-ad5-ncov-booster-in-pediatric-liver-transplant-recipients
#19
JOURNAL ARTICLE
Zhigang Zheng, Huimin Wu, Xiaowei Sun, Yefeng Lu, Yanyan Song, Yi Luo, Tao Zhou, Mingxuan Feng, Ping Wan, Jianjun Zhu, Nan Shen, Qing Cao, Ji Liang, Qiang Xia, Feng Xue
Amidst the COVID-19 pandemic, uncertainty persists among caregivers regarding the vaccination of pediatric liver transplant recipients (PLTRs). This study evaluates the immunogenicity and safety of COVID-19 vaccination in this vulnerable population. A cohort of 30 PLTRs underwent sequential vaccinations with an inactivated SARS-CoV-2 vaccine followed by an Ad5-nCoV booster. We collected and analyzed blood samples pre-vaccination and four weeks post-vaccination to quantify antibody and IGRA (IFN-γ Release Assay) levels...
March 2024: Journal of Medical Virology
https://read.qxmd.com/read/38525999/polyacrylamide-gel-versus-hyaluronic-acid-for-the-treatment-of-knee-osteoarthritis-a-randomised-controlled-study
#20
JOURNAL ARTICLE
Henning Bliddal, Jannie Beier, Andreas Hartkopp, Philip G Conaghan, Marius Henriksen
OBJECTIVES: To assess non-inferiority of intra-articular injectable polyacrylamide hydrogel (iPAAG) to hyaluronic acid (HA) on symptomatic benefit in individuals with knee osteoarthritis (OA). METHODS: This randomised, controlled, multi-centre trial recruited adults with symptomatic and radiographic knee OA from 3 clinical rheumatology sites in Denmark; two private clinics and one public hospital department. Participants were randomised 1:1 to receive a single intra-articular 6 mL injection of either HA or iPAAG on an outpatient basis...
March 19, 2024: Clinical and Experimental Rheumatology
keyword
keyword
46457
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.